Impact of the Diabetes Canada guidelines dissemination Strategy on the prescription of vascular protective medications in Canada

dc.contributor.author	Sullivan, Francis
dc.date.accessioned	2018-09-20T15:30:10Z
dc.date.available	2018-09-20T15:30:10Z
dc.date.issued	2017-11-11
dc.identifier	250652623
dc.identifier	9b12a37b-e301-420a-95bb-63a778c9d23e
dc.identifier.citation	Sullivan , F 2017 , ' Impact of the Diabetes Canada guidelines dissemination Strategy on the prescription of vascular protective medications in Canada ' , Diabetes Canada. Canadian Society of Endocrinology and Metabolism Professional Conference and Annual Meetings , Edmonton , Canada , 1/11/17 - 4/11/17 .	en
dc.identifier.citation	conference	en
dc.identifier.other	ORCID: /0000-0002-6623-4964/work/48516884
dc.identifier.uri	https://hdl.handle.net/10023/16053
dc.format.extent	574119
dc.language.iso	eng
dc.subject	RC Internal medicine	en
dc.subject	RM Therapeutics. Pharmacology	en
dc.subject	SDG 3 - Good Health and Well-being	en
dc.subject.lcc	RC	en
dc.subject.lcc	RM	en
dc.title	Impact of the Diabetes Canada guidelines dissemination Strategy on the prescription of vascular protective medications in Canada	en
dc.type	Conference poster	en
dc.contributor.institution	University of St Andrews. School of Medicine	en
dc.contributor.institution	University of St Andrews. Population and Behavioural Science Division	en
dc.description.status	Non peer reviewed	en
dc.date.embargoedUntil	2017-11-11